Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow. It is called “acute” because of its aggressive nature, and “lymphoblastic” because it affects a group of white blood cells known as lymphocytes. You may have also heard ALL referred to as acute lymphocytic leukemia. While ALL is rare in adults, it is the most common type of pediatric cancer.
Treatment options for ALL include chemotherapy, targeted therapy, immunotherapy and stem cell transplants. In addition, ongoing research is leading to promising new therapies. Despite being an acute — or fast-growing cancer — ALL is considered a treatable and sometimes curable disease. In most cases, it is important to start treatment for ALL soon after diagnosis and to work with a hematologist/oncologist who specializes in the disease.
To learn more about acute lymphoblastic leukemia, navigate to "What is ALL?"